QEII Halifax Infirmary Emergency Department is working with reduced space, which may lead to delays for those with less urgent concerns. Learn more here.

Nova Scotia Health has made changes to parking and the main entrance of the QEII Halifax Infirmary. Learn more.

Vedolizumab (Entyvio®) Therapy

Categories

Medications

Digestive System

Attachment

Last Update

January 1, 2022

Extension

.pdf

Print Code

QV85-1623

Language

English

Creator

Nova Scotia Collaborative IBD Program

Vedolizumab (Entyvio®) is given to manage inflammatory bowel disease (IBD), ulcerative colitis, or Crohn's disease. This pamphlet gives you information about vedolizumab to help you make an informed decision about whether or not to use it.

Employee Resources